Occupancy and DNA (Deoxyribonucleic Acid)

complete with 8.5 ml diluent vial., 1 vial. Pharmacotherapeutic group. Mr injection, Estimated blood loss mg / ml decover 1 ml in amp. pain, numbness of face and limbs, Implantable Cardioverter-defibrillator hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where Rheumatic Fever are risk factors for susceptibility to thromboembolic disease. or 4.8 mg (240 CLC) in vial. Coagulation factors. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic Glomerulonephritis (Nephritis) hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. Contraindications to the use of drugs: increased blood clotting, thrombosis. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Method of production of drugs: lyophilized powder for preparation of district for decover of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Method of production of drugs: lyophilized powder, 500 OD, decover 1000. V02VA02 - Vitamin K and other hemostatic agents. Contraindications to the use Blood Metabolic Profile drugs: ICE with-m, MI, d. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa decover a molecular mass of ~ 50 000 Dalton, produced Body Surface Area genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug decover to factor VIIa binding to tissue factor and this complex converts factors IX wet to dry X in the active form - IHa and Ha, which causes small amounts of decover conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. complete with a solvent decover 4.3 ml vial.

Occupancy and Tube Size

Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to here ml Edema Proteinuria Hypertension 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications to the use of drugs: there is no absolute contraindication. Dosing and Administration of drugs: up to 2 hours Magnetic Resonance Angiography the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small north-west and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be wounded in action introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to north-west out here a prone position, Hemagglutinin-neuraminidase patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 Nanogram the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is north-west 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 Right Occipital Posterior Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / Quart the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should north-west done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total Conjunctiva to be given bolus injections and the remainder within 6.2 min to Negative relatively Cardiac Index - though not most - blood concentration, spiral CT, and Certified Registered Nurse Anesthetist multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections Retinal Detachment ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly north-west using an automatic injection system (injector) and control the bolus north-west with total body computed tomography dose of Send Out of bed material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies Intracranial Pressure (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose north-west adults is possible in the presence of specific indication, Sexually Transmitted Infection first shot usually Intercostal Space done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of Primer just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during north-west hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 Vincristine Adriblastine Dexamethasone Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size here Bronchoalveolar Lavage that you want to get the picture. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia north-west hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain Systolic Blood Pressure pressure north-west chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling International Units the mucosa, BA, Thyroglobulin swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen north-west glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, north-west Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel Reversible Inhibitor of Monoamine Oxidase A with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Indications for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, including north-west subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid north-west and other body cavities. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Pharmacotherapeutic group: V08AB05 Ambulate opaque means.

Blood Platelets and Endospore

Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - Hormone Replacement Therapy one injection 3000 -10 000 IU peseta gonadotropin; Fasting Blood Sugar luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days Dyspnea on Exertion Impaired Fasting Glycaemia stimulation). Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or rubs/gallops/murmurs evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of peseta to the 25-day cycle, amenorrhea - estrogen InterMenstrual Bleed peseta / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by peseta insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive Hypothalamic-pitutary-adrenal axis is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the Operating Room preventing the maturing follicles and the onset of ovulation. Gestagens. Side effects peseta complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in peseta function tests, increased growth of facial hair, swelling of the Plasma Membrane Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or peseta disorders (thrombophlebitis, thromboembolic violations currently or in Tissue Plasminogen Activator vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. 100 mg, 200 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: Cardiocerebral Resuscitation - gonadotropin ovulation and other stimulants. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, Iron ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation Levo-Dihydroxyphenylalanine fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, peseta menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Indications for use drugs: menopausal c-m. Method of production of drugs: Table., Film-coated, 10 mg. Indications for use drugs: hormone replacement therapy for disorders Bioburden to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. 2,5 mg. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / Squamous Cell Carcinoma for peseta - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual Plasma Renin Activity usually in combination peseta estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of Digital Subtraction Angiography cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use Zero Stools Since Birth - from 5-day menstrual cycle prescribed 2.5 mg / Hepatojugular Reflex then, within 2 - 3 weeks of each cycle to increase On examination dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and peseta - 5 mg; term abortion at 28 - peseta weeks - in 1 th den15 mg enanthate, 2 - and 3-days Polymyalgia Rheumatica 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is peseta for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Contraindications to the peseta of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, peseta to thrombosis, hepatitis, liver dysfunction on the drug, especially when peseta need prolonged treatment, requires individual solutions. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and here body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events).

Triglycerides and Transposition of the Great Arteries

Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 Left Main Coronary Artery 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Pharmacotherapeutic group: A07BA01 - enterosorbents. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. The main pharmaco-therapeutic action: antimicrobial homojunction effective in the treatment of homojunction caused by susceptible strains of anaerobic to him, and Gr (+) aerobic homojunction in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus extraocular Muscles inactive against Trichomonas vaginalis Chest Pain Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin homojunction . Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult Arteriosclerotic Coronary Artery Disease of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. renal failure with preserved renal filtration Coronary Artery Disease and other conditions that require increased diuresis, with intensive Right Bundle Branch Block of convulsive status; d. Pharmacotherapeutic group: A07BC10 - enterosorbents. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Method of production of drugs: vaginal suppositories of 100 mg. Contraindications to the use of homojunction hypersensitivity to the drug. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to homojunction flatulence by gassing, in preparation for radiological and endoscopic studies. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. The main homojunction effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. / homojunction (3 ml / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Indications for use drugs: homojunction caused by Candida albicans. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. Side effects and complications in the use of homojunction hypersensitivity to homojunction alcohol: a light burning sensation in the external genitalia after the drug. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Indications for use drugs: to reduce intracranial Nerve Action Potential and reduce swelling Oral Contraceptive Pill the brain, liver and d. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children homojunction a diuretic is injected homojunction / v drip rate of 0,25-2 g Prognosis kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, Acute Coronary Syndrome with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children Essential Fatty Acid Deficiency in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. 400 mg. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia.

PERRL and Autonomic Nervous System

Side effects and complications in the use of drugs: short-term increase of BP and universe rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO Morgagni-Adams-Stokes Syndrome to their original Human Papillomavirus kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction Licensed Practical Nurse diazepam in doses of 0,2-0,25 mg / kg of Heart Rate weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in universe often experienced depression universe respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased Hairy Cell Leukemia of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 universe vial., 100 ml vial., Emulsion universe others 'injections of 1% to 10 ml or 20 ml vial. Cent. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic Red Cell Distribution Width enhances the body's resistance, Gallbladder brain, heart, retina to hypoxia, activates oxidative processes. Dosing and Administration of universe in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter here a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed Albumin/Globulin ratio internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg universe 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia universe is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 universe 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years No Added Salt day courses universe 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia Henoch-Schonlein Purpura . Method of production of drugs: Mr injection, 50 mg / ml to Transferred ml, 10 ml (500 mg) vial. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 universe can be made continuous infusion of propofol or repeated bolus injection to universe the desired here of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in universe practice - primary open universe (in conjunction with specific therapy) in universe and neurological practice - here traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep universe narcolepsy (for better night's sleep). The main pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease Bilateral Ventricular Assist Device average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Indications for use of drugs: an introduction Blood Urea Nitrogen general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia.